Literature DB >> 7512031

CD5 is associated with the human B cell antigen receptor complex.

A C Lankester1, G M van Schijndel, J L Cordell, C J van Noesel, R A van Lier.   

Abstract

On human B cells the antigen receptor complex is composed of the membrane form of the immunoglobulin molecule and the non-covalently associated Ig alpha/beta heterodimer. A small subpopulation of normal B cells and chronic lymphocytic leukemia B cells express (analogous to T cells) the transmembrane molecule CD5, a counterstructure of B cell-specific CD72. Numbers of CD5+ B cells are increased in several physiological and pathological conditions. Moreover, CD5+ B cells are being held responsible for the production of autoreactive antibodies and seem to have signaling characteristics distinct from conventional B cells. On T cells, CD5 associates with the T cell receptor CD3 complex and ligation of CD5 leads to the generation of co-stimulatory signals, that act on T cell activation. We here demonstrate that CD5 is associated with the B cell receptor (BCR) complex and serves as substrate for BCR-induced tyrosine kinase activity. Hence, CD5+ B cells have a unique potential to modulate BCR signals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512031     DOI: 10.1002/eji.1830240406

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.

Authors:  J J Perez-Villar; G S Whitney; M A Bowen; D H Hewgill; A A Aruffo; S B Kanner
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.

Authors:  Robert Berland; Steven Fiering; Henry H Wortis
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

3.  Induction of murine CD5 expression by v-H-ras.

Authors:  T R Weichert; R C Schwartz
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  Developmental expression of B cell molecules in equine lymphoid tissues.

Authors:  J M B Prieto; R L Tallmadge; M J B Felippe
Journal:  Vet Immunol Immunopathol       Date:  2016-12-13       Impact factor: 2.046

5.  CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis.

Authors:  G H Cantor; S M Pritchard; F Dequiedt; L Willems; R Kettmann; W C Davis
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Authors:  Jorge Vera; Rafael Fenutría; Olga Cañadas; Maite Figueras; Rubén Mota; Maria-Rosa Sarrias; David L Williams; Cristina Casals; José Yelamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

Review 7.  Microanatomy of the liver immune system.

Authors:  Eszter Nemeth; Alan W Baird; Cliona O'Farrelly
Journal:  Semin Immunopathol       Date:  2009-07-29       Impact factor: 9.623

8.  B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes.

Authors:  H H Wortis; M Teutsch; M Higer; J Zheng; D C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

9.  Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens.

Authors:  Julio Delgado; Torsten Bielig; Lizette Bonet; Elena Carnero-Montoro; Xose S Puente; Dolors Colomer; Elena Bosch; Elias Campo; Francisco Lozano
Journal:  Br J Haematol       Date:  2016-03-15       Impact factor: 6.998

10.  Multiple regulatory mechanisms control B-1 B cell activation.

Authors:  Vishal J Sindhava; Subbarao Bondada
Journal:  Front Immunol       Date:  2012-12-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.